Unknown

Dataset Information

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.


ABSTRACT: Excessive iron absorption is one of the main features of β-thalassemia and can lead to severe morbidity and mortality. Serial analyses of β-thalassemic mice indicate that while hemoglobin levels decrease over time, the concentration of iron in the liver, spleen, and kidneys markedly increases. Iron overload is associated with low levels of hepcidin, a peptide that regulates iron metabolism by triggering degradation of ferroportin, an iron-transport protein localized on absorptive enterocytes as well as hepatocytes and macrophages. Patients with β-thalassemia also have low hepcidin levels. These observations led us to hypothesize that more iron is absorbed in β-thalassemia than is required for erythropoiesis and that increasing the concentration of hepcidin in the body of such patients migh

SUBMITTER: Gardenghi S 

PROVIDER: S-EPMC2993583 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature